George A. Scangos

2013 - Biogen

In 2013, George A. Scangos earned a total compensation of $15M as Chief Executive Officer at Biogen, a 12% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$89,477
Non-Equity Incentive Plan$3,560,480
Salary$1,498,462
Stock Awards$9,195,217
Other$671,511
Total$15,015,147

Scangos received $9.2M in stock awards, accounting for 61% of the total pay in 2013.

Scangos also received $89.5K of change in pension value and nonqualified deferred compensation earnings, $3.6M in non-equity incentive plan, $1.5M in salary and $671.5K in other compensation.

Rankings

In 2013, George A. Scangos' compensation ranked 177th out of 12,286 executives tracked by ExecPay. In other words, Scangos earned more than 98.6% of executives.

ClassificationRankingPercentile
All
177
out of 12,286
99th
Division
Manufacturing
52
out of 4,612
99th
Major group
Chemicals And Allied Products
15
out of 1,466
99th
Industry group
Drugs
10
out of 1,160
99th
Industry
Biological Products, Except Diagnostic Substances
2
out of 200
99th
Source: SEC filing on April 15, 2016.

Scangos' colleagues

We found five more compensation records of executives who worked with George A. Scangos at Biogen in 2013.

2013

Douglas Williams

Biogen

Former EVP, Research and Development

2013

Paul Clancy

Biogen

Chief Financial Officer

2013

Raymond Pawlicki

Biogen

Former SVP, Chief Information Officer

2013

Stuart Kingsley

Biogen

Former EVP, Global Operations

2013

John Cox

Biogen

EVP, Pharmaceutical Operations and Technology

You may also like